Interventions for Central Serous Chorioretinopathy: A Network Meta-Analysis
August 2015
in “
Cochrane Database of Systematic Reviews
”
TLDR The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.
The document outlined a protocol for a network meta-analysis to compare the effectiveness of various interventions for central serous chorioretinopathy (CSC). It aimed to include randomized controlled trials (RCTs) involving adults with CSC, comparing treatments like laser photocoagulation, photodynamic therapy, anti-VEGF agents, and other medical treatments. Primary outcomes included changes in best-corrected visual acuity (BCVA) over 12 months, while secondary outcomes focused on recurrence rates, persistent CSC, and adverse events. The study emphasized the need for a comprehensive review to establish a treatment hierarchy and identify promising therapies for CSC.
